Abstract. Two abietane and one labdane type diterpenoids were isolated from the methanol extracts of Torreya nucifera pulp and investigated for their ability to inhibit the growth of human cancer cells. among the three compounds, the labdane compound kayadiol was found to have the most effective inhibitory effect against a wide variety of human cancer cells. using the MTT assay, kayadiol was determined to have an ic 50 (50% inhibition concentration) of 30 µM in Hela cells, and also to exhibit anti-proliferative effects towards six other human cancer cell lines, with ic 50 values of 30-50 µM. Kayadiol treatment of Hela cells resulted in a dose-dependent generation of apoptotic events, including dna laddering (≤100 µM). Moreover, kayadiol-treated HeLa cells showed activation of caspases-3 and -9, as well as an increase in the depolarization of mitochondrial membrane potential and the Bax/Bcl-2 ratio. These results indicate that a mitochondriarelated apoptotic pathway is involved in the kayadiol-induced death of Hela cells. Kayadiol is therefore a promising novel anti-proliferative agent and merits further investigation.
Introduction
Plants are known to contain chemical compounds that inhibit the proliferation of cancer-derived cells in vitro. numerous attempts have been made to isolate anti-cancer drugs from plants. For example, the diterpene paclitaxel (Taxol ® ) is a well-known anti-proliferative agent isolated from Taxus brevifolia (1, 2) . Various research has been conducted on other diterpenoid species, with the aim of identifying more effective agents for the treatment of cancer (3) . We recently isolated a diterpenoid compound, sarcodonin G, from Sarcodon scabrosus, and demonstrated its anti-proliferative activity on human cancer cells (4) . Torreya nucifera is an evergreen coniferous tree that is commonly found in areas of Japan, Korea and china (5) . The seeds of this tree exhibit significant insecticidal activity (6) , while the fruit is widely used in folk medicine for the treatment of tapeworm infestation (in Korea) and for the induction of abortion (in Japan) (7) . To date, analyses of the cell growth inhibition activities of Torreya nucifera have been focused on extracts from its leaves and wood (8) , and a number of sesquiterpenoids isolated from the wood oil of the tree were reported to have an inhibitory effect on cell growth (9) . However, there have been no reports on diterpenoids isolated from the pulp of the tree, although the pulp may contain numerous intriguing chemical compounds.
in the present study, two abietane diterpenoids, 18-hydroxyferruginol (8, 11, 13-abietatriene-12, 18-diol) (10) and hinokiol (8, 11, 13-abietatriene-3, 12-diol) (11) , and a labdane diterpenoid, kayadiol [8(17) , 13-labdiene-15,18-diol] (Fig. 1) (12, 13) , were isolated from the pulp of Torreya nucifera. There is little available information on the biological activity of these isolated chemical compounds; thus, we investigated their inhibitory activity on the growth of cancer cells. among the three compounds, kayadiol was found to exert the greatest growth inhibition in a wide variety of human cancer cells.
Materials and methods
Agents. labdane and abietane diterpenoids were isolated from the air-dried pulp of Torreya nucifera according to previously reported methods (14) . Briefly, air-dried pulp (1.3 kg) was extracted with 10 l methanol at room temperature. The combined organic extracts were evaporated under reduced pressure. Water (1 l) and then hexane (1 l) were added and the mixture was well agitated, then lipids in the upper hexane Anti-proliferative and apoptosis-inducible activity of labdane and abietane diterpenoids from the pulp of Torreya nucifera in HeLa cells The structures of the labdane and abietane diterpenoid compounds were elucidated on the basis of spectral data (Fig. 1) . each of the isolated compounds was dissolved in dimethyl sulfoxide (dMSo) (Wako Pure chemical industry, osaka, Japan). The characteristics of the isolated chemical compounds have been reported elsewhere (15) . Unless specifically stated, the other reagents were purchased from Wako Pure chemical industry.
Cells and culture conditions. The following human cell lines were used: Hela (a cervical cancer cell line) (16), u251-SP (a glioma cell line) (17), Hac-2 (an ovarian carcinoma cell line) (17), T-Tn (a esophageal carcinoma cell line) (18), T-98 (a glioma cell line) (18), Hec-1 (an endometrial adenocarcinoma cell line) (18) and Hle (a hepatoma cell line) (18) . cells were cultured in eagle's minimal essential medium (eMeM) (Gibco Brl, Grand island, ny, uSa) containing 10% (v/v) calf serum (intergen, ny, uSa) and antibiotics (100 µg/ml streptomycin and 100 u/ml penicillin G) (Meiji Seika, Tokyo, Japan) at 37˚C in a humidified atmosphere containing 5% CO 2 .
Measurement of cell viability. cell viability was determined by the MTT assay as previously described (19) . Briefly, logarithmically proliferating cells were plated onto 96-well plates (asahi Glass, Tokyo, Japan) (5x10 3 cells/well) with medium containing the test compounds at the indicated doses, followed by culture for 2 days. The activity of mitochondrial succinic dehydrogenase was measured by further incubation of the cells with 0.5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2-,5-diphenyl tetrazolium bromide (MTT) (Sigma, St. louis, Mo, uSa) for 4 h, followed by measurement of absorbance at 570 nm with a reference wavelength of 655 nm. cell survival was calculated from the absorbance and presented as a percentage of the surviving cells.
Measurement of cell-cycle phase distribution. cell-cycle phase distributions were measured as previously described (20). Briefly, cells were cultured in 60-mm dishes with the test compounds (up to 100 µM) for 24 h followed by trypsinization, then washed three times with phosphate-buffered saline (PBS) and fixed in 70% cold ethanol. After fixation, the cells were suspended in staining solution [50 µg/ml propidium iodide (Pi), 4 mM sodium citrate, 0.5 mg/ml rnase a and 0.1% Triton X-100] for 10 min on ice. nacl was then added to the solution to a final concentration of 0.15 M. The stained cell samples were analyzed using a FacScan instrument (Becton dickinson, nJ, uSa). The percentage of cells undergoing apoptosis was measured by calculating sub-G1 fractions using cellQuest software (Becton dickinson). cell-cycle phase distribution measurements were repeated in three different cultures.
DNA fragmentation analysis. apoptotic dna fragments were detected as previously described (21) . Briefly, cells treated with vehicle and the test compounds (up to 100 µM) were cultured for 48 h and then lysed for 3 h at 37˚C in a solution containing 50 mM Tris-Hcl (pH 8.0), 2 mM edTa, 1% SdS and 100 µg/ ml proteinase K. Following the addition of 1/10 volume of 3 M sodium acetate, nucleotides were extracted with phenol/ chloroform, and then with chloroform alone. High molecular weight dna was precipitated by the addition of 7/10 volume of 2-propanol followed by centrifugation at 15,000 rpm for 5 sec at room temperature. low molecular weight dna was recovered from the supernatant by centrifugation after incubation overnight at -20˚C, then re-suspended in 10 mM Tris-HCl (pH 8.0), 1 mM edTa and 50 µg/ml of dnase-free rnase a, and finally incubated for 3 h at 37˚C. Samples were applied to 1.5% agarose gel containing 0.5 µg/ml ethidium bromide and electrophoresed in 90 mM Tris-borate (pH 8.0) and 2 mM edTa at 100 V for 3 h. dna ladders were photographed under uV illumination.
Immunoblotting analysis. immunoblotting analysis was carried out as previously described (20). after treatment with the test compounds for the indicated periods, cells were solubilized in 1X SdS sampling buffer. The whole cell lysates were separated by electrophoresis on 12% (w/v) SdS-PaGe. active forms of caspase-3 and -9 proteins were detected using rabbit anti-cleaved caspases-3 antibody (2305-Pc-020; Trevigen, Md, uSa) (1:800 dilution) and mouse anti-human caspase-9 antibody (MaB8301; r&d, Minneapolis, Mn, uSa) (1:1,000 dilution), respectively. The latter antibody detects non-cleaved and cleaved caspase-9. Bax and Bcl-2 proteins were detected using mouse anti-Bax monoclonal antibody (Santa cruz Biotechnology, Santa cruz, ca, uSa) (1:300 dilution) and mouse anti-Bcl-2 monoclonal antibody (Santa cruz Biotechnology) (1:300 dilution), respectively. The antigen-antibody complexes were detected by anti-rabbit igG (na934V; Ge, Healthcare, uK) and anti-mouse igG (na931V; amersham Biosciences, Buckinghamshire, uK), followed by visualization using the ecl system (Ge). amounts of actin were also analyzed by mouse anti-actin antibody (illkirch, France) (1:20,000 dilution) as the loading control. The intensities of the protein signals were quantified using Multi Gauge ver. 2.2 image analyzing software (Fuji Foto Film, Tokyo, Japan) and expressed as the relative value to that of actin.
Measurement of mitochondrial membrane potential.
Mitochondrial membrane potential was measured using a florescent probe 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodide (Jc-1) (cell Technology inc., Mountain View, ca, uSa) according to the manufacturer's instructions (22) . as the membrane is hyperpolarized, Jc-1 accumulates as aggregates in the mitochondria and stains red. When the membrane potential is depolarized, Jc-1 exists as a monomeric form in the cytosol and stains green. cells were cultured in 60-mm dishes with and without the indicated compounds at the indicated doses for 24 h followed by trypsinization, then suspended in culture medium containing JC-1 and incubated at 37˚C in a 5% CO 2 incubator for 15 min. Thereafter, the cells were washed once with EMEM, and fluorescence was measured by FACScan. The ratio of green fluorescence (FL1) intensity to red fluorescence (Fl2) intensity was used to determine the extent of the depolarization of mitochondrial membrane potential.
Statistical analysis.
Values are expressed as the means of two or more independent experiments, unless specifically stated otherwise, and were compared to results from a vehicle-treated (0.1% dMSo) control. Statistical analysis was performed using the Student's t-test with StatView software (ver. 4.5; abacus concepts, Berkeley, ca, uSa) as previously described (20).
Results

Inhibition of HeLa cell viability by kayadiol.
The cytotoxic potential of three labdane and abietane diterpenoid compounds ( Fig. 1) was determined using the MTT assay after culture of Hela cells in the presence of the chemical compounds (up to 100 µM) for 2 days. Hinokiol treatment resulted in only a slight decrease in cell viability at 100 µM (Fig. 2a) . The inhibitory effect of 18-hydroxyferruginol treatment on cell viability was greater than that of hinokiol, while kayadiol treatment inhibited cell viability to the greatest extent (Fig. 2a) . in a more precise MTT analysis, kayadiol showed an anti-proliferative effect towards Hela and Hle cells with an ic 50 value of 30 and 50.3 µM, respectively (Fig. 2B and Table i ). The ic 50 values of kayadiol in five other human cancer cell lines ranged between 30 and 50 µM (Table i) . Hela cells showed the highest sensitivity to the anti-proliferative effect of kayadiol among all the cancer cell lines tested.
Apoptotic events in kayadiol-treated HeLa cells. cell cycle distribution in the HeLa cells was examined by flow cytometric analysis after Pi staining. cells treated with 18-hydroxyferruginol (up to 100 µM ) for 24 h showed only a slight increase in the sub-G1 phase cell population (apoptotic fraction) (Fig. 3a) . By contrast, a distinct dose-dependent increase in the apoptotic fraction was observed in cells treated with kayadiol (Fig. 3a) . These results indicate that apoptosis was induced in kayadiol-treated HeLa cells. To confirm that kayadiol induced apoptosis, the fragmentation status of genomic dna was examined in Hela cells treated with the compound. The results were compared to the distinct dna fragmentation observed in Hela cells treated with cisplatin (100 µM) (Fig. 3B) . dna fragmentation was observed in cells treated with 50 and 100 µM of kayadiol (Fig. 3B ), but not in cells treated with 18-hydroxyferruginol (up to 100 µM).
Involvement of mitochondria-related pathways in apoptosis in kayadiol-treated HeLa cells.
To elucidate the mechanisms of kayadiol-induced apoptosis in the Hela cells, the possible involvement of the caspases was assessed by detecting the active cleaved forms of caspases-3 and -9. The active form of caspase-3 was detected after 24 h of treatment with 50 µM kayadiol, and was further increased in cells treated with 100 µM kayadiol (Fig. 4a ). after treatment with 50 and 100 µM kayadiol, the amount of active caspase-9 was also increased, by ~3-fold in cells treated with 100 µM kayadiol as compared to the control (Fig. 4a) . 
C
The activation of caspase-9 suggested the involvement of a mitochondria-related pathway in kayadiol-induced apoptosis. Thus, mitochondrial membrane potential in Hela cells was measured using the JC-1 florescent probe. After kayadiol treatment at 50 and 100 µM, a reduction in membrane potential was observed (Fig. 4B) . Treatment with 100 µM kayadiol resulted in depolarization to a similar extent as treatment with 50 µM cisplatin.
next, the protein concentrations of Bax and Bcl-2, which are involved in mitochondria-related apoptosis, were measured in Hela cells treated with and without kayadiol. Western blot analysis showed that the expression of Bcl-2 protein decreased after kayadiol treatment (50-100 µM), while the Bax/Bcl-2 protein ratio increased in a time-dependent manner until 24 h of treatment (Fig. 4c) . after 10 h of treatment with 100 µM kayadiol, the ratio was slightly increased, whereas after 24 h of treatment, it was increased by ~2-fold.
Discussion
of the three chemicals extracted from Torreya nucifera pulp, kayadiol exhibited the greatest inhibition of Hela cell viability, as determined by the MTT assay (Fig. 2a) . The sensitivity of Hela cells to kayadiol was similar to their sensitivity to another diterpenoid, sarcodonin G (4). The growth inhibition of Hela cells by kayadiol (Fig. 2) and sarcodonin G was greater than that induced by 5-Fu, but weaker than that of cisplatin (4) . chemotherapeutic anti-cancer agents, including 5-Fu and cisplatin, are known to induce apoptosis (23, 24) . in the present study, this was demonstrated by dna fragmentation observed in cisplatin-treated Hela cells (Fig. 3B) . Kayadiol (at concentrations in excess of 50 µM) also induced apoptotic events in Hela cells, as evidenced by an increase in the percentage of cells in the sub-G1 fraction (Fig. 3a) , dna fragmentation (Fig. 3B ) and the activation of caspase-3 (Fig. 4a) , as well as of caspase-9. caspase-9 is thought to be activated by an apoptotic signal via mitochondria-dependent mechanisms, and further cleaves and activates the other effector caspases, including caspase-3 (25, 26) . Here, mitochondrial membrane potential was depolarized in kayadiol-treated Hela cells (Fig. 4B ). Bax and Bcl-2 protein levels were also modulated in the kayadiol-treated Hela cells (Fig. 4c) . Bax and Bcl-2 are pro-and anti-apoptotic proteins, respectively (27) . up-regulation of the Bax/Bcl-2 ratio suggests the involvement of mitochondrial factors in caspase activation (28) (29) (30) . in the present study, the Bax/Bcl-2 ratio was increased in Hela cells treated with kayadiol (at concentrations in excess of 50 µM) (Fig. 4c) .
Generally, apoptosis occurs via the mitochondrial (intrinsic) pathway (31) or the death receptor (extrinsic) pathway (32) . The mitochondrial (intrinsic) pathway is controlled at the level of the mitochondrial membrane by the Bcl-2 superfamily of proteins. an increase in the expression ratio of the proapoptotic family of proteins vs. the anti-apoptotic family of proteins leads to the disruption of mitochondrial membrane potential and the activation of caspase-9 (25, (28) (29) (30) . Therefore, it is possible that kayadiol treatment (at concentrations in excess of 50 µM) induced the activation of at least the intrinsic mitochondria-related apoptotic pathway in Hela cells.
The viability of six other human cancer cell lines was decreased by kayadiol treatment. The ic 50 values of kayadiol in the other cell lines ranged between 30 and 50 µM. Thus, kayadiol may have a lethal effect in a wide variety of cancer cells.
From a structure-activity perspective, it would be informative to investigate which functional groups of kayadiol contribute to its substantial anti-proliferative activity. We are now isolating other diterpenoids from various plants, particularly from Taxus mairei (33) , and searching for novel diterpenoids that have greater anti-proliferative activity in human cancer cells than kayadiol.
